Drugs /

5-ht3 receptor antagonist

Back to Drugs List

Overview

NCI Definition [1]:
Any agent that binds to and blocks serotonin (5-HT) type 3 receptors. This group of agents is used to treat nausea, vomiting, and irritable bowel syndrome. Some of the 5-HT3 antagonists also show antipsychotic efficacy.

Clinical Trials

View Clinical Trials for 5-ht3 receptor antagonist

5-ht3 receptor antagonist has been investigated in 1 clinical trial, of which 0 are open and 1 is closed. Of the trial investigating 5-ht3 receptor antagonist, 1 is phase 1 (0 open).

Drug Details

Synonyms [2]:
serotonin 5-ht3 receptor antagonists, 5-ht3 receptor antagonist, 5-ht3 receptor antagonist (substance), antagonist, 5-ht3, 5-ht>3< receptor antagonist, 5-ht3 antagonists, serotonin 5 ht3 receptor antagonists, 5-hydroxytryptamine-3-receptor antagonist (product), 5-ht3 receptor antagonist (substance), 5-hydroxytryptamine-3-receptor antagonist, 5-ht3 receptor antagonist, 5-ht3-receptor antagonist, 5 ht3 antagonist, antagonists, 5-ht3, 5-ht3 antagonist, 5-hydroxytryptamine 3 receptor antagonist, 5-ht>3< receptor antagonist (substance), 5 ht3 antagonists, type 3 serotonin receptor antagonist
NCIT ID [1]:
C94726
SNOMED ID [1]:
C-85830

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.